ENSG (72) EHC (77) PACS (74) THC (74) ⌘ Pro Terminal →

Universal Health Services Inc. (UHS) — RQD Stock Rating Cockpit

$176.05 -0.32% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $175.61

Universal Health Services Inc. (UHS) carries a Roarable Rating of C (Hold) with 63/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

📊 Historical Track Record: Scores of 63/100 (C) historically posted market-perform odds over rolling 90-day windows (+0.9% avg 90D alpha vs SPY) →

ROARABLE C • HOLD / WATCH Cap $10.41B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on UHS Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is UHS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, Universal Health Services Inc. (NYSE: UHS) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 63/100 at a spot price of $176.05 (-0.32% 1D, market cap $10.41B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 15/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 18/20. Across 1016 tracked Health Care issuers, UHS ranks #145 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does UHS compare to ENSG and EHC in the Health Care sector?

▼

Within the Health Care sector (Hospital/Nursing Management), UHS carries a Roarable C (63/100 RQD), trailing P/E of 7.0x, gross margin of —, and ROIC of 14.1%. By comparison, ENSG (The Ensign Group Inc.) holds a B grade (72/100 RQD, P/E 31.6x, ROIC 18.0%, cap $10.87B) and EHC (Encompass Health Corporation) posts a B+ grade (77/100 RQD, P/E 22.9x, ROIC 13.8%, cap $12.97B). Among the 5-stock peer group, UHS leads on earnings multiple (7.0x) while THC leads on capital efficiency (27.6% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for UHS?

▼

Per UHS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000352915), Universal Health Services Inc. generated $17.36B in revenue (+9.7% YoY), $1.49B in net income, and $849.2M in free cash flow against $15.53B in total assets and $4.00B in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $175.61 (-0.25%)🧬 Cannibal Buyback (-2.92% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 4.9% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 63/100 (C) historically posted market-perform odds over rolling 90-day windows (+0.9% avg 90D alpha vs SPY • 54.8% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C · Rk C

Each axis scored 0–20

12M PRICE TARGET CONE+2.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for UHS)Realized 20D OHLCV Swing Band: ±6.8%

Deterministic 5-Pillar Attribution (63/100 Composite)

🔍 WHY UHS SCORES 63/100 (C) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Insider Conviction & Share Dilution+18/20 pts (29% of score)

SEC Form 4 / 13F Thermometer: 86% Net Buy • Cannibal Buyback (-2.92% YoY Shares)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+15/20 pts (24% of score)

Altman Z-Score 3.11 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 9/9

▼ #1 Drag / Risk Factor: Macro Regime Fit10/20 pts (-10 pt drag)

Macro rate sensitivity & RSI-14 (46.5) create a -10 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade B$179.01+3.7% Next Q

Q2 (-2Q)

Grade B-$185.61-4.5% Next Q

Q3 (-1Q)

Grade B-$177.32-0.7% Next Q

Current

Grade C$176.05+0.9% Hist 90D α

Trajectory: B (71) → C (63)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the UHS Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 63/100 (C) score, UHS faces multiple-compression risk if 7.0x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.92% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($177.27) or 200D SMA ($176.73) invalidates the momentum regime and cuts Target Base ($180.01) toward Bear Floor ($140.41).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $UHS• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “UHS Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 63%NO 37%Trade / Inspect Odds →

RSI-14 MOMENTUMNEUTRAL RANGE

46.530 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

3.11>3.0 Fortress Safe

PIOTROSKI F-SCOREHIGH QUALITY (7–9)

9 / 99-Pt Accounting

52-WEEK LASER RANGE34% OF RANGE

L: $140$176.05H: $246

1. Money & Cash Health● WEAK

Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: DRQD 10 / 20

2. Big Money & Insiders● BUYING

Are whales & executives buying or selling?

Hedge funds and options traders are leaning bullish, showing strong institutional appetite.

Factor Grade: B-RQD 28 / 40

3. Hidden Risks & Market Weather● WATCH

SEC fine-print scan & interest-rate fit

No major SEC filing blowups, though current interest rates and Fed liquidity call for normal position sizing.

Factor Grade: CRQD 25 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

JEV AI Jury Split (Battleground) on UHS

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BEARISH (50)

14.1% ROIC with 42.0% gross margin and 8.16% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BULLISH (75)

Altman-Z 3.11 and Piotroski 9/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

NEUTRAL (63)

28/40 institutional & smart-money positioning score with 10/20 macro alignment.

Bull Case: Why Buyers Like UHS

✓Company leadership has skin in the game with net positive insider conviction.
✓Clean SEC annual filing review with no major hidden accounting time-bombs.

Bear Case: What Could Go Wrong

!Sensitive to high interest rates and tighter Federal Reserve market liquidity.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (UHS Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

UHS // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +6.01%▲ ASCENDING CHANNEL

2026-11-02O $172.2H $176.6L $172.2C $176.1VOL 1.01M

RES: $194.2SUP: $169.4SMA50: $177.3SMA200: $176.7

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

UHS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 UHS Butterfly Map → + Track UHS →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

-8.0%/yr Implied 5Y Growth

vs. +9.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on UHS today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for UHS. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for UHS today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (UHS)

Health Care Rank #145 of 1016 ⚔️ ENSG vs UHS Full Matrix →

1. Head-to-Head Health Care Peer Comparison (UHS vs. ENSG, EHC, PACS, THC)

Industry: Hospital/Nursing Management (14 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Universal Health Services Inc. (UHS) ranks #145 by composite RQD confidence (63/100, grade C) and #107 by equity capitalization ($10.41B). Within this direct 5-issuer industry benchmark cohort, UHS leads on earnings valuation at 7.0x trailing P/E, while THC leads on capital efficiency and profitability with 27.6% ROIC and — gross margin. EHC currently holds the highest overall quantitative score in the immediate peer group at 77/100 (B+) compared with UHS at 63/100 (C).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
UHS ACTIVE Universal Health Services Inc.	C	63/100	7.0x	—	14.1%	-0.32%	$10.41B	Benchmark Subject
ENSG The Ensign Group Inc.	B	72/100	31.6x	20.1%	18.0%	-2.58%	$10.87B	/ensg-vs-uhs →
EHC Encompass Health Corporation	B+	77/100	22.9x	—	13.8%	+3.35%	$12.97B	/ehc-vs-uhs →
PACS PACS Group Inc.	B	74/100	41.1x	—	24.6%	-3.76%	$7.87B	/pacs-vs-uhs →
THC Tenet Healthcare Corporation	B	74/100	9.2x	—	27.6%	+0.99%	$21.79B	/thc-vs-uhs →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000352915

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Universal Health Services Inc. (UHS) reported GAAP revenue of $17.36B (+9.7% vs. FY2024 revenue of $15.83B , and +21.6% cumulative change since FY2023) , GAAP net income of $1.49B, operating cash flow of $1.86B, and free cash flow of $849.2M (-24.4% YoY). On the balance sheet, UHS closed FY2025 with $15.53B in total assets against $4.00B in total debt (Altman Z-Score: 3.11, Piotroski F-Score: 9/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$17.36B	$1.49B	$1.86B	$849.2M	$15.53B	$4.00B
FY2024 (FY)	2024-12-31	$15.83B	$1.14B	$2.07B	$1.12B	$14.47B	$4.46B
FY2023 (FY)	2023-12-31	$14.28B	$717.8M	$1.27B	$625.1M	$17.14B	$4.01B

3. UHS Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is UHS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does UHS compare to ENSG and EHC in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for UHS?

Where is UHS trading relative to its 50-day, 200-day, and 52-week technical levels?

UHS last traded at $176.05 (-0.32% on volume of 582,236 shares), positioning the stock -0.69% below its 50-day simple moving average ($177.27) and -0.38% below its 200-day simple moving average ($176.73). Across its 52-week range of $140.08 to $246.33, UHS sits at the 33.9% percentile with a 14-day RSI of 46.5 (NEUTRAL RANGE) and an implied next-earnings move of ±6.8% ($164.08 to $188.02).

UHS Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell UHS stock right now?

Universal Health Services Inc. (UHS) currently earns a Roarable Rating of C (Hold — HOLD) with 63/100 RQD Confidence. Solid steady margins (14% return on capital), mixed timing at 7x P/E—hold if owned, no rush to chase.

What is UHS's 12-month price target and RQD AI Jury consensus?

UHS's 12-month base price target is $180.01 (range $140.41 to $258.65), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: UHS RQD Cockpit UHS 12M Forecast UHS Earnings & Move UHS Dividends & DRIP UHS Insiders & 13F UHS Whale Options UHS Profit Sankey UHS News & Why

ROARABLE RATING BRIEF • RQD 63/100 (C) ✓ STAGE-C NUMBER FIREWALL VERIFIED

UHS — Universal Health Services Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:16:24Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, UHS scores 63 out of 100, a letter grade of C, with the verdict "Roarable Hold — Fair / Balanced Risk-Reward." The five pillars are:

Fundamental Cash Engine: 10 / 20. The rating cites ROIC of 14.1% and an FCF yield of 8.16%. Strong cash returns are offset by a score that sits in the middle of the range, suggesting the engine is productive but not decisively superior.
Whale 13F Flow: 10 / 20. The rating references institutional accumulation and options positioning. The pillar is mid-range, so institutional signals are present but not strongly directional in the source data.
Insider Conviction: 18 / 20. This is the strongest pillar, citing SEC Form 4 and Congressional PTR cluster flow. For a prospective investor, the high score is the most notable positive signal in the rating, though the underlying trade-level detail is not included in the source data.
Macro Regime Fit: 10 / 20. The rating cites a beta of 1.04 and sector sensitivity. Beta near 1.0 implies market-like volatility, and the mid-range score indicates the stock's fit with the current macro regime is neutral rather than favorable.
Forensic Balance Sheet: 15 / 20. The rating cites an Altman Z of 3.11, a Piotroski F of 9/9, and Debt/Equity of 0.55. The strong Piotroski reading and healthy Z-Score support balance sheet quality, the highest-scoring element after insider flow.

Translated for an investor: the rating describes a company with solid cash generation, a credible balance sheet, and notable insider buying signals, offset by a neutral macro fit and only moderate institutional conviction. The valuation metrics in the market data (forward P/E of 6.5, EV/EBITDA of 5) are low, which could represent upside if earnings hold, but also may reflect market concern the source data does not explain. The verdict of "Hold" reflects this balance between upside drivers and unresolved risks.

Snapshot

Price	Market Cap	P/E (TTM)	Forward P/E	EV/EBITDA	EPS (TTM)	Dividend Yield	Beta	52-Wk Range	ROIC %
176.61	$10.41B	7	6.5	5	25.26	0.49%	1.04	$140.08 - $246.33	14.1%

Business

Universal Health Services Inc. (UHS) is a NYSE-listed issuer in the Health Care sector, operating in the Hospital/Nursing Management industry. The source profile identifies it as a hospital and nursing management operator. Per the SEC financials, revenue for FY 2025 was $17364.8M. Not available in source data for detailed customer segmentation or revenue model breakdown.

Financial Trend

Period	Revenue	Operating Income	Net Income	EPS	FCF	Cash	Debt
FY 2025	$17364.8M	$1994.0M	$1488.8M	N/A	$849.2M	$137.8M	$4004.4M
FY 2024	$15827.9M	$1681.8M	$1142.1M	N/A	$1123.3M	$126.0M	$4464.5M
FY 2023	$14282.0M	$1175.4M	$717.8M	N/A	$625.1M	N/A	$4010.4M

Per the SEC financials, revenue grew from $14282.0M in FY 2023 to $17364.8M in FY 2025, and net income rose from $717.8M to $1488.8M over the same span. Per the market data, operating margin is 11.5%, net margin is 8.6%, and gross margin is reported as 0%. Per the Roarable RQD rating, ROIC is 14.1%, the Altman Z-Score is 3.11, and the Piotroski F-Score is 9/9. Debt declined from $4464.5M in FY 2024 to $4004.4M in FY 2025, and the Debt/Equity ratio is 0.55 per the rating.

Recent Catalysts & News Wire Analysis

Per the recent news feed, the headlines include a modest fair value cut following mixed analyst views (RISK WATCH), a bearish Seeking Alpha piece titled with a claimed 134% upside (RISK WATCH), an earnings preview (MARKET WIRE), a report that UHS missed Q3 earnings estimates despite higher patient volumes (RISK WATCH), a GuruFocus report on Q3 2026 earnings with an EPS figure cut off in the source (MARKET WIRE), and a second earnings preview (MARKET WIRE). Four items are flagged RED/RISK WATCH and two are YELLOW/MARKET WIRE. The Butterfly supply-chain graph reports no supply chain and no proprietary signals. The source data does not contain the EPS figure for Q3 2026 or the full text of the articles.

Open Questions

What is the Q3 2026 EPS figure, and how did it compare to estimates? The news feed references a miss but the source does not provide the number.
What drove the low forward P/E (6.5) and EV/EBITDA (5), and does the market price in risks the source data does not describe?
What are the specific insider and Congressional transactions behind the 18/20 insider conviction score?
Which revenue segments drive growth from $14282.0M to $17364.8M, and how much is organic versus acquired?
Why is the gross margin reported as 0%, and how should that be interpreted given the other margin figures?

UHS Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Universal Health Services Inc. (UHS) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to UHS Debate Forum (3) ↓

🔴 RISK WATCH Yahoo Finance • 8h ago

Universal Health Services (UHS) Stock Sees Modest Fair Value Cut After Mixed Analyst Views

Yahoo Finance report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH Seeking Alpha • 11h ago

Universal Health: Bears Have Taken It Too Far - 134% Upside (NYSE:UHS)

Seeking Alpha report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 14h ago

Earnings Preview: What to Expect From Universal Health Services’ Report

Yahoo Finance report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH TradingView • 17h ago

UHS Misses Q3 Earnings Estimates Despite Higher Patient Volumes

TradingView report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE GuruFocus • 20h ago

Universal Health Services Inc Reports Q3 2026 Earnings: EPS of $

GuruFocus report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 23h ago

Universal Health Services earnings: what to look for from UHS

Yahoo Finance report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingView • 1d ago

Universal Health Services’s Q3 earnings call: our top 5 analyst questions

TradingView report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

Universal Health Services, Inc. (UHS) Stock Forecasts

Yahoo Finance report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

UHS Bull vs. Bear Conversation Board — What's Your Call at $176.05?

🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON UHS 🐻 50% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST 🎯 Target: $190.74 (+8.0%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is UHS (C • RQD 63/100) a Buy at $176.61?

Welcome to the UHS (Universal Health Services Inc.) Roar Pit. Current RQD Composite is 63/100 (Roarable Hold — Fair / Balanced Risk-Reward) in Hospital/Nursing Management. Bulls point to capital efficiency (14.1% ROIC), while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

SK SkepticalCFA Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $137.76 (-22.0%)

Spot @ $176.61

Pump the brakes on UHS — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on UHS, but look at what you are paying: 7.0x trailing P/E with tightening sector spreads. Unless Universal Health Services Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

MI MidwestValue Verified K Arena Trader 🐂 BULLISH 🎯 Target: $203.10 (+15.0%)

Spot @ $176.61

UHS cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on UHS, the market is fixating on short-term headline noise in Hospital/Nursing Management and ignoring the balance sheet and cash flow trajectory. At $176.61 (52-wk range $140.08 - $246.33), any beat on forward guidance forces shorts and underweight funds to chase.